Defining success with HIV pre-exposure prophylaxis
نویسندگان
چکیده
منابع مشابه
Defining the HIV pre-exposure prophylaxis care continuum
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. There is little scientific consensus about how to measure PrEP program implementation progress. We draw on several years of experience in implementing PrEP programs and propose a PrEP continuum of care that includes: (1) identifying individuals at highest risk for contracting HIV, (2) increasing HIV risk awareness among th...
متن کاملPre-Exposure Prophylaxis for HIV Prevention.
c ase vignet tes The first patient, a 46-year-old sexually active man who has sex with men, presents for routine primary care. He lives in New York City and reports that he is in a long-term, stable, open relationship with a male partner and that he has had multiple recent sexual encounters with acquaintances. A recent HIV test was negative. He has seasonal allergies, for which he occasionally ...
متن کاملHIV pre-exposure prophylaxis for women
Women and girls comprise nearly half of HIV-infected individuals globally and 20% of new infections in the United States, indicating an urgent need to optimise HIV prevention options in this population. HIV pre-exposure prophylaxis (PrEP) - where antiretrovirals are administered to HIV-non-infected individuals at risk of HIV acquisition - is a promising, female-controlled HIV prevention strateg...
متن کاملPreparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxis.
Although RCTs have not been conducted to establish the effıcacy of non-occupational postexposure prophylaxis (nPEP), studies in nonhuman primates have demonstrated protection with nPEP; observational data support the effıcacy of PEP for occupational exposures; and several studies have esablished the feasibility of nPEP delivery in various setings. Based on these data, the CDC and public health ...
متن کاملPre-exposure Prophylaxis (PrEP)
In 2012, the US Food and Drug Administration (FDA) approved Truvada to be used as PrEP by HIV negative people who are at high risk of sexually acquired HIV infection. The US Centre for Disease Control has since developed guidelines and recommended PrEP be used by people at high risk of HIV acquisition via sexual transmission or injection drug use (http://www.cdc.gov/hiv/prevention/research/prep/).
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: AIDS
سال: 2015
ISSN: 0269-9370
DOI: 10.1097/qad.0000000000000647